We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Influenza Vaccine Research Progress and Opportunities Go Under the Magnifying Glass

News   Apr 09, 2019 | Original story from the National Institutes of Health.

 
Influenza Vaccine Research Progress and Opportunities Go Under the Magnifying Glass

Colorized structure of a prototype for a universal flu vaccine. The nanoparticle is a hybrid of a protein scaffold (blue) and eight influenza hemagglutinin proteins on the surface (yellow). Credit: NIAID.

 
 
Advertisement
 

RELATED ARTICLES

KRAS Inhibitor Sotorasib Achieves Durable Clinical Benefit in Early Trial

News

In a Phase I clinical trial for patients with advanced solid cancers marked by KRAS G12C mutations, the KRASG12C inhibitor sotorasib (AMG 510) resulted in manageable toxicities and durable clinical benefit.

READ MORE

Could Psoriatic Arthritis Be Activated by the Same Receptor in Different Patients?

News

A new study has revealed psoriatic arthritis may be activated by the same trigger in different patients. Researchers identified high levels of a specific receptor in immune cells, giving promising evidence of a single cause for the disease.

READ MORE

Drug Shown To Modulate the Inflammatory Response in Severe COVID-19

News

Scientists have identified a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE